Core Insights - The Rehabilitation Hospital of Fort Myers aims to provide essential rehabilitative services for patients recovering from various conditions, including strokes and spinal cord injuries, with a focus on regaining function and independence [1] - The hospital features advanced rehabilitation technologies and a comprehensive care approach, including physical, occupational, and speech therapies [2][3] - Encompass Health operates the hospital as part of its extensive network, which includes 168 inpatient rehabilitation hospitals across the United States [4] Company Overview - Encompass Health is the largest owner and operator of inpatient rehabilitation hospitals in the U.S., with a presence in 38 states and Puerto Rico [4] - The company is recognized for its high-quality rehabilitative care and has received accolades from Fortune and Forbes for its workplace environment and trustworthiness [4] Partnership and Community Impact - The partnership between Encompass Health and Lee Health aims to enhance access to high-quality rehabilitative care in the Fort Myers community [3] - Lee Health has a long-standing history in Southwest Florida, evolving to meet community health needs since 1916 [6]

Core Viewpoint - Encompass Health (EHC) has been upgraded to a Zacks Rank 1 (Strong Buy), indicating a positive outlook on its earnings estimates, which significantly influence stock prices [1][3]. Earnings Estimates and Stock Price Impact - The Zacks rating system is based on changes in earnings estimates, which are strongly correlated with stock price movements, particularly due to institutional investors adjusting their valuations based on these estimates [4][6]. - For the fiscal year ending December 2025, Encompass Health is expected to earn $4.98 per share, reflecting a 12.4% increase from the previous year, with a 5.5% rise in the Zacks Consensus Estimate over the past three months [8]. Zacks Rating System - The Zacks Rank system classifies stocks into five groups based on earnings estimates, with Zacks Rank 1 stocks historically generating an average annual return of +25% since 1988 [7]. - Only the top 5% of Zacks-covered stocks receive a 'Strong Buy' rating, indicating superior earnings estimate revisions, which positions Encompass Health favorably for potential market-beating returns [9][10].

Company Overview - Encompass Health Corp. is the largest owner and operator of inpatient rehabilitation hospitals in the United States, with a national footprint of 167 hospitals across 38 states and Puerto Rico [2] - The company provides high-quality rehabilitative care for patients recovering from major injuries or illnesses, utilizing advanced technology and innovative treatments to maximize recovery [2] - Encompass Health has received recognition as one of Fortune's World's Most Admired Companies™, Becker's Hospital Review's 150 Top Places to Work in Healthcare, and Forbes' Most Trusted Companies in America [2] Upcoming Events - Encompass Health will participate in the BofA Securities 2025 Healthcare Conference from May 13-15, 2025 [1] - Doug Coltharp, Executive Vice President and Chief Financial Officer, will engage in a fireside chat on May 13, 2025, from 8:40-9:10 a.m. PT [1] - The presentation will be available via live webcast at investor.encompasshealth.com [1]

Core Viewpoint - Encompass Health Corp. has promoted Patrick Tuer to the newly established position of Chief Operating Officer (COO) to oversee hospital operations, reflecting the company's significant growth and strategic expansion in rehabilitative care [1][2][3] Company Overview - Encompass Health is the largest owner and operator of inpatient rehabilitation hospitals in the United States, with a national footprint of 167 hospitals across 38 states and Puerto Rico [4] - The company is recognized for providing high-quality rehabilitative care, utilizing advanced technology and innovative treatments to maximize patient recovery [4] Leadership and Strategy - Patrick Tuer's promotion to COO is aimed at enhancing operational success and overseeing the company's expanding portfolio of hospitals, which is integral to the company's strategy of improving access to high-quality rehabilitative care [2][3] - Tuer has a strong background in leadership roles within the healthcare sector, having previously served as group president, regional president, and regional vice president at Encompass Health since 2018 [3] Growth and Development - The company is focused on an accelerated de novo program and capacity additions to existing hospitals, which are key components of its growth strategy [3] - Encompass Health's development pipeline is described as robust, indicating expectations for continued growth in the future [3]

Core Viewpoint - Encompass Health Corporation reported strong first-quarter results for 2025, with significant revenue and earnings growth, leading to an increase in full-year guidance for key financial metrics [1][4]. Financial Performance - Net operating revenue for Q1 2025 was $1,455.4 million, a 10.6% increase from $1,316.0 million in Q1 2024, reflecting a growth of $139.4 million [2][9]. - Income from continuing operations attributable to Encompass Health per diluted share rose to $1.48, up 33.3% from $1.11 in the previous year [2][14]. - Adjusted earnings per share increased by 22.3% to $1.37 from $1.12 [2][21]. - Cash flows from operating activities increased by 20.9% to $288.6 million compared to $238.8 million in Q1 2024 [2][18]. - Adjusted EBITDA for the quarter was $313.6 million, a 14.9% increase from $273.0 million [2][20]. Operational Highlights - Total discharges increased by 6.3% to 64,985, with same-store discharge growth of 4.4% [2][9]. - Net patient revenue per discharge grew by 3.9% to $21,816 from $20,990 [2][9]. - The company opened one new 40-bed hospital and added 25 beds to existing facilities during the quarter [3]. Updated Guidance - The company raised its full-year guidance for 2025, with net operating revenue now expected to be between $5,850 million and $5,925 million, up from the previous range of $5,800 million to $5,900 million [4]. - Adjusted EBITDA guidance was updated to a range of $1,185 million to $1,220 million, compared to the previous guidance of $1,160 million to $1,200 million [4]. - Adjusted earnings per share from continuing operations is now projected to be between $4.85 and $5.10, an increase from the prior range of $4.67 to $4.96 [4].

Core Viewpoint - Encompass Health Corp. has rescheduled its 2025 first quarter earnings call to 9 a.m. ET on April 25, 2025, following the release of its financial results after market close on April 24, 2025 [1] Company Information - Encompass Health is the largest owner and operator of inpatient rehabilitation hospitals in the United States, with 167 hospitals across 38 states and Puerto Rico [3] - The company provides high-quality rehabilitative care for patients recovering from major injuries or illnesses, utilizing advanced technology and innovative treatments [3] - Encompass Health has received recognition as one of Fortune's World's Most Admired Companies™, Becker's Hospital Review's 150 Top Places to Work in Healthcare, and Forbes' Most Trusted Companies in America [3]